Scavenger effect of experimental and clinically used cardiovascular drugs

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 5, 2001, Pages 745-753

  Marton, Zsolt ^a,d   Halmosi, Robert ^a,d   Horvath, Beata ^a,d   Alexy, Tamas ^a,d   Kesmarky, Gabor ^a,d   Vekasi, Judit ^a,b,d   Battyany, Istvan ^a,b,d   Hideg, Kalman ^a,c,d   Toth, Kalman ^a,d  

^a Division of Cardiology   (Hungary)

^b Department of Ophthalmology ^*

^c Institute of Organic and Medicinal Chemistry   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Antioxidant; Cardiovascular; Oxygen free radical; Red blood cell filtration

Indexed keywords

ALPHA TOCOPHEROL; AMIODARONE; CARDIOVASCULAR AGENT; CARVEDILOL; H 2433; H 2434; H 2545; H 2954; METOPROLOL; MEXILETINE; NIFEDIPINE; OXYGEN RADICAL; PHENAZINE METHOSULFATE; PROCAINAMIDE; PROPAFENONE; SCAVENGER; SOTALOL; TIMOLOL; TRIMETAZIDINE; TROLOX C; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ERYTHROCYTE FILTERABILITY; FILTRATION; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; CARBAZOLES; CARDIOVASCULAR AGENTS; ERYTHROCYTES; FREE RADICAL SCAVENGERS; HUMANS; INDOLES; MALE; METHYLPHENAZONIUM METHOSULFATE; MEXILETINE; PROPANOLAMINES; PYRROLES; SOTALOL;

EID: 0034770194     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200111000-00011     Document Type: Article

References (31)

1. Free radicals and their involvement during long-term myocardial ischemia and reperfusion
2. Oxygen free radicals in the pathophysiology of myocardial ischemia/reperfusion
3. Reperfusion of infarcted tissue and free radicals
4. Generation of superoxide in cardiomyocytes during ischemia before reperfusion
5. Free radicals in disease
6. Low density lipoprotein oxidation, antioxidants, and atherosclerosis
7. Oxidation-induced changes in microrheologic properties of the red blood cell membrane
8. Lipid peroxidation in human red cells
9. Effect of superoxide anions on red blood cell rheologic properties
10. Activated granulocyte induced alterations in red blood cells and protection by antioxidant enzymes
11. In vivo oxidative modification of erythrocyte membrane proteins in copper deficiency
12. A new hypothesis about the relationship between free radical reactions and hemorheological properties in vivo
13. Effects of oxidative damage of membrane protein thiol groups on erythrocyte membrane viscoelasticities
14. Effects of superoxide anions on red cell deformability and membrane proteins
15. In vitro method for measurement of free radical effects: Effect of PMS (phenazine methosulphate) on red blood cell membrane
16. Increase of red blood cell suspension viscosity caused by free radical generator
17. Simple method for the measurement of antioxidants
18. The new St. George's blood filtrometer
19. Antiarrhythmic agents: Scavengers of hydroxyl radicals and inhibitors of NADPH-dependent lipid peroxidation in bovine lung microsomes
20. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation
21. Comparative antioxidant activities of propanolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation
22. In vitro study on antioxidant potential of various drugs used in the perioperative period
23. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action
24. A comparison of carvedilol and metoprolol antioxidant activities in vitro
25. The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals
26. Targeted antioxidant properties of N-[(tetramethyl-3-pyrroline-3-carboxamido)-propyl]phthalimide and its nitroxide metabolite in preventing postischemic myocardial injury
27. New antiarrhythmic agents 2,2,5,5,-tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5,-tetramethylpyrrolidine-3-carboxamides
28. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide
29. Direct evidence for in vivo nitroxide free radical production from a new anti-arrhythmic drug by EPR spectroscopy
30. A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction